Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.0017 | 0.0411 | 0.0119 |
Brugia malayi | Nuclear hormone receptor family member nhr-1 | 0.0017 | 0.0411 | 0.1157 |
Echinococcus granulosus | FTZ F1 alpha | 0.0017 | 0.0411 | 0.0119 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.0017 | 0.0411 | 0.0131 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.0017 | 0.0411 | 0.0119 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0017 | 0.0411 | 0.0411 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.0017 | 0.0411 | 0.0131 |
Loa Loa (eye worm) | steroid hormone receptor | 0.0017 | 0.0411 | 0.1157 |
Brugia malayi | flavodoxin family protein | 0.0026 | 0.129 | 1 |
Leishmania major | p450 reductase, putative | 0.0026 | 0.129 | 1 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0017 | 0.0411 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0026 | 0.129 | 0.129 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.0017 | 0.0411 | 0.1157 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0026 | 0.129 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0023 | 0.0994 | 0.5 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.0017 | 0.0411 | 0.0119 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.0017 | 0.0411 | 0.1157 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.0017 | 0.0411 | 0.0411 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0411 | 0.1157 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0411 | 0.1157 |
Brugia malayi | Nuclear hormone receptor family member nhr-14 | 0.0017 | 0.0411 | 0.1157 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.0017 | 0.0411 | 0.1157 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0017 | 0.0411 | 0.1157 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0026 | 0.129 | 0.1025 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0026 | 0.129 | 0.1131 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.0017 | 0.0411 | 0.1157 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0017 | 0.0411 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0026 | 0.129 | 0.5 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.0017 | 0.0411 | 0.0119 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0026 | 0.129 | 0.5 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0026 | 0.129 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0026 | 0.129 | 0.1025 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | 0.0104 | 0.9091 | 1 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0017 | 0.0411 | 0.5 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.0017 | 0.0411 | 0.0131 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0411 | 0.1157 |
Schistosoma mansoni | coup transcription factor | 0.0017 | 0.0411 | 0.0411 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.0017 | 0.0411 | 0.0411 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0026 | 0.129 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-3 | 0.0017 | 0.0411 | 0.1157 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.0017 | 0.0411 | 0.0131 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.0017 | 0.0411 | 0.1157 |
Trypanosoma cruzi | p450 reductase, putative | 0.0026 | 0.129 | 0.5 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0026 | 0.129 | 0.5 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.0017 | 0.0411 | 0.0119 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0026 | 0.129 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0026 | 0.129 | 0.5 |
Brugia malayi | nuclear hormone receptor | 0.0017 | 0.0411 | 0.1157 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0026 | 0.129 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0026 | 0.129 | 0.5 |
Schistosoma mansoni | nuclear hormone receptor | 0.0017 | 0.0411 | 0.0411 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.0017 | 0.0411 | 0.1157 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.0017 | 0.0411 | 0.0411 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0016 | 0.0296 | 0.0296 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0017 | 0.0411 | 0.0131 |
Brugia malayi | ecdysteroid receptor | 0.0017 | 0.0411 | 0.1157 |
Brugia malayi | Nuclear hormone receptor family member nhr-40 | 0.0017 | 0.0411 | 0.1157 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.129 | 1 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.0017 | 0.0411 | 0.0411 |
Brugia malayi | steroid hormone receptor | 0.0017 | 0.0411 | 0.1157 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.0017 | 0.0411 | 0.1157 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0411 | 0.1157 |
Brugia malayi | Nuclear hormone receptor family member nhr-31 | 0.0017 | 0.0411 | 0.1157 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0026 | 0.129 | 0.5 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.0017 | 0.0411 | 0.0119 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0113 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0411 | 0.1157 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0411 | 0.1157 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0026 | 0.129 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0411 | 0.1157 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.0017 | 0.0411 | 0.1157 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.0017 | 0.0411 | 0.1157 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.0017 | 0.0411 | 0.0131 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.0017 | 0.0411 | 0.1157 |
Schistosoma mansoni | thyroid hormone receptor | 0.0017 | 0.0411 | 0.0411 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0411 | 0.1157 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.0017 | 0.0411 | 0.0411 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0026 | 0.129 | 1 |
Echinococcus multilocularis | FTZ F1 alpha | 0.0017 | 0.0411 | 0.0131 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0026 | 0.129 | 0.1131 |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.0017 | 0.0411 | 0.0131 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.0017 | 0.0411 | 0.1157 |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | 0.0017 | 0.0411 | 0.1157 |
Schistosoma mansoni | thyroid hormone receptor | 0.0017 | 0.0411 | 0.0411 |
Chlamydia trachomatis | sulfite reductase | 0.0016 | 0.0296 | 0.5 |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.0017 | 0.0411 | 0.0119 |
Brugia malayi | nuclear receptor NHR-88 | 0.0017 | 0.0411 | 0.1157 |
Onchocerca volvulus | 0.0017 | 0.0411 | 0.5 | |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.0017 | 0.0411 | 0.1157 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0023 | 0.0994 | 0.5 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.0017 | 0.0411 | 0.0411 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.0017 | 0.0411 | 0.1157 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.0017 | 0.0411 | 0.1157 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0017 | 0.0411 | 0.1157 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.0017 | 0.0411 | 0.1157 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.0017 | 0.0411 | 0.0411 |
Brugia malayi | FAD binding domain containing protein | 0.0026 | 0.129 | 1 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.0017 | 0.0411 | 0.0131 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 60.4 uM | In vivo anticonvulsant activity was measured as median effective dose required to prevent tonic phase of seizure in DBA/2 mice | ChEMBL. | 15027880 |
ED50 (functional) | = 60.4 uM | In vivo anticonvulsant activity was measured as median effective dose required to prevent tonic phase of seizure in DBA/2 mice | ChEMBL. | 15027880 |
ED50 (functional) | = 105 uM | In vivo anticonvulsant activity was measured as median effective dose required to prevent clonic phase of seizure in DBA/2 mice | ChEMBL. | 15027880 |
ED50 (functional) | = 105 uM | In vivo anticonvulsant activity was measured as median effective dose required to prevent clonic phase of seizure in DBA/2 mice | ChEMBL. | 15027880 |
ED50 (functional) | = 60.4 uM kg-1 | Anticonvulsant activity against audiogenic seizures in DBA/2 mice (value required to prevent tonic phases of seizures). | ChEMBL. | 9719593 |
ED50 (functional) | = 60.4 uM kg-1 | Anticonvulsant activity against audiogenic seizures in DBA/2 mice (value required to prevent tonic phases of seizures). | ChEMBL. | 9719593 |
ED50 (functional) | = 105 uM kg-1 | Anticonvulsant activity against audiogenic seizures in DBA/2 mice (value required to prevent clonic phases of seizures). | ChEMBL. | 9719593 |
ED50 (functional) | = 105 uM kg-1 | Anticonvulsant activity against audiogenic seizures in DBA/2 mice (value required to prevent clonic phases of seizures). | ChEMBL. | 9719593 |
Rm | = 0.575 | Relative lipophilicity | ChEMBL. | 9719593 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.